Sorrento Therapeutics, Inc.
Anti-KRAS Binding Proteins

Abstract:

The present disclosure provides anti-KRAS antibodies, and antigen-binding fragments thereof. In certain embodiments, the anti-KRAS antibodies or fragments thereof, are used for the treatment of cancer.